SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 128 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $421,000 | +25.7% | 28,128 | +2.2% | 0.01% | 0.0% |
| Q1 2016 | $335,000 | -30.2% | 27,529 | -8.8% | 0.01% | -16.7% |
| Q4 2015 | $480,000 | +14.0% | 30,183 | +9.8% | 0.01% | 0.0% |
| Q3 2015 | $421,000 | -39.9% | 27,492 | -4.7% | 0.01% | -40.0% |
| Q2 2015 | $701,000 | -1.3% | 28,845 | -5.6% | 0.01% | +25.0% |
| Q1 2015 | $710,000 | +7.1% | 30,547 | +15.7% | 0.01% | 0.0% |
| Q4 2014 | $663,000 | -17.0% | 26,393 | +2.7% | 0.01% | -27.3% |
| Q3 2014 | $799,000 | +3.1% | 25,691 | -14.3% | 0.01% | +10.0% |
| Q2 2014 | $775,000 | -23.6% | 29,983 | -30.9% | 0.01% | -23.1% |
| Q1 2014 | $1,014,000 | +160.7% | 43,377 | +182.9% | 0.01% | +116.7% |
| Q4 2013 | $389,000 | +80.9% | 15,335 | +45.5% | 0.01% | +20.0% |
| Q3 2013 | $215,000 | – | 10,541 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 462,824 | $7,364,000 | 8.63% |
| HealthCor Management, L.P. | 1,750,000 | $27,843,000 | 1.69% |
| ACUTA CAPITAL PARTNERS, LLC | 144,667 | $2,302,000 | 1.10% |
| THB ASSET MANAGEMENT | 615,546 | $9,793,000 | 1.05% |
| Penn Capital Management Company, LLC | 1,399,205 | $22,261,000 | 0.98% |
| Tamarack Advisers, LP | 450,000 | $7,160,000 | 0.94% |
| Piermont Capital Management Inc. | 139,020 | $2,212,000 | 0.70% |
| JW Asset Management, LLC | 101,630 | $1,617,000 | 0.60% |
| SECTORAL ASSET MANAGEMENT INC | 810,362 | $12,893,000 | 0.55% |
| Glacier Peak Capital LLC | 50,000 | $796,000 | 0.51% |